539 related articles for article (PubMed ID: 33012322)
1. Biologics for Atopic Dermatitis.
Boguniewicz M
Immunol Allergy Clin North Am; 2020 Nov; 40(4):593-607. PubMed ID: 33012322
[TBL] [Abstract][Full Text] [Related]
2. The Role of Interleukins 4 and/or 13 in the Pathophysiology and Treatment of Atopic Dermatitis.
Silverberg JI; Kantor R
Dermatol Clin; 2017 Jul; 35(3):327-334. PubMed ID: 28577802
[TBL] [Abstract][Full Text] [Related]
3. Dupilumab for the treatment of adolescents with atopic dermatitis.
Senner S; Seegräber M; Frey S; Kendziora B; Eicher L; Wollenberg A
Expert Rev Clin Immunol; 2020 Jul; 16(7):641-650. PubMed ID: 32720530
[TBL] [Abstract][Full Text] [Related]
4. Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approaches.
Moyle M; Cevikbas F; Harden JL; Guttman-Yassky E
Exp Dermatol; 2019 Jul; 28(7):756-768. PubMed ID: 30825336
[TBL] [Abstract][Full Text] [Related]
5. IL-13 antagonists in the treatment of atopic dermatitis.
Tubau C; Puig L
Immunotherapy; 2021 Mar; 13(4):327-344. PubMed ID: 33430628
[TBL] [Abstract][Full Text] [Related]
6. Dupilumab after the 2017 approval for the treatment of atopic dermatitis: what's new and what's next?
van der Schaft J; Thijs JL; de Bruin-Weller MS; Balak DMW
Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):341-349. PubMed ID: 31145194
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of biologics in atopic dermatitis.
Wu J; Guttman-Yassky E
Expert Opin Biol Ther; 2020 May; 20(5):525-538. PubMed ID: 32003247
[No Abstract] [Full Text] [Related]
8. Improvement of atopic dermatitis with dupilumab occurs equally well across different anatomical regions: data from phase III clinical trials.
Blauvelt A; Rosmarin D; Bieber T; Simpson EL; Bagel J; Worm M; Deleuran M; Katoh N; Kawashima M; Shumel B; Chen Z; Rossi AB; Hultsch T; Ardeleanu M
Br J Dermatol; 2019 Jul; 181(1):196-197. PubMed ID: 30719707
[No Abstract] [Full Text] [Related]
9. New and Emerging Biologics for Atopic Dermatitis.
Baghoomian W; Na C; Simpson EL
Am J Clin Dermatol; 2020 Aug; 21(4):457-465. PubMed ID: 32323259
[TBL] [Abstract][Full Text] [Related]
10. Weight gain in patients with severe atopic dermatitis treated with dupilumab: a cohort study.
Johansson EK; Ivert LU; Bradley B; Lundqvist M; Bradley M
BMC Dermatol; 2020 Sep; 20(1):8. PubMed ID: 32962676
[TBL] [Abstract][Full Text] [Related]
11. Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapy.
D'Erme AM; Romanelli M; Chiricozzi A
Drug Des Devel Ther; 2017; 11():1473-1480. PubMed ID: 28553077
[TBL] [Abstract][Full Text] [Related]
12. Biologics and Allergy Immunotherapy in the Treatment of Allergic Diseases.
Cox L
Immunol Allergy Clin North Am; 2020 Nov; 40(4):687-700. PubMed ID: 33012328
[TBL] [Abstract][Full Text] [Related]
13. Dupilumab: A review of its use in the treatment of atopic dermatitis.
Gooderham MJ; Hong HC; Eshtiaghi P; Papp KA
J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S28-S36. PubMed ID: 29471919
[TBL] [Abstract][Full Text] [Related]
14. Novel systemic drugs in treatment of atopic dermatitis: results from phase II and phase III studies published in 2017/2018.
Werfel T
Curr Opin Allergy Clin Immunol; 2018 Oct; 18(5):432-437. PubMed ID: 30095475
[TBL] [Abstract][Full Text] [Related]
15. Early and Long-Term Effects of Dupilumab Treatment on Circulating T-Cell Functions in Patients with Moderate-to-Severe Atopic Dermatitis.
Bakker DS; van der Wal MM; Heeb LEM; Giovannone B; Asamoah M; Delemarre EM; Drylewicz J; Nierkens S; Boyman O; de Bruin-Weller MS; Thijs JL; van Wijk F
J Invest Dermatol; 2021 Aug; 141(8):1943-1953.e13. PubMed ID: 33610558
[TBL] [Abstract][Full Text] [Related]
16. The IL-13-OVOL1-FLG axis in atopic dermatitis.
Furue K; Ito T; Tsuji G; Ulzii D; Vu YH; Kido-Nakahara M; Nakahara T; Furue M
Immunology; 2019 Dec; 158(4):281-286. PubMed ID: 31509236
[TBL] [Abstract][Full Text] [Related]
17. Onset of Schamberg Disease and Resolution of Alopecia Areata During Treatment of Atopic Dermatitis With Dupilumab.
Szekely S; Vaccari D; Salmaso R; Belloni-Fortina A; Alaibac M
J Investig Allergol Clin Immunol; 2021 Feb; 31(1):65-66. PubMed ID: 32490817
[No Abstract] [Full Text] [Related]
18. Current and emerging biologics for the treatment of pediatric atopic dermatitis.
Ghamrawi R; Bell KA; Balogh EA; Strowd LC; Feldman SR
Expert Opin Biol Ther; 2020 Dec; 20(12):1435-1445. PubMed ID: 33078990
[TBL] [Abstract][Full Text] [Related]
19. Novel Therapeutic Approaches and Targets for the Treatment of Atopic Dermatitis.
Pescitelli L; Rosi E; Ricceri F; Pimpinelli N; Prignano F
Curr Pharm Biotechnol; 2021; 22(1):73-84. PubMed ID: 32525769
[TBL] [Abstract][Full Text] [Related]
20. Are Biologics Efficacious in Atopic Dermatitis? A Systematic Review and Meta-Analysis.
Snast I; Reiter O; Hodak E; Friedland R; Mimouni D; Leshem YA
Am J Clin Dermatol; 2018 Apr; 19(2):145-165. PubMed ID: 29098604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
